{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:18:47Z","timestamp":1773289127544,"version":"3.50.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1054\/clnu.2001.0429","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"379-391","source":"Crossref","is-referenced-by-count":10,"title":["The metabolic puzzle during the evolution of HIV infection"],"prefix":"10.1054","volume":"20","author":[{"given":"J.","family":"SALAS-SALVAD\u00d3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"GARC\u00cdA-LORDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/clnu.2001.0429_RF1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcn\/50.3.444","article-title":"Magnitude of body cell mass depletion and the timing of death from wasting in AIDS","volume":"50","author":"Kotler","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1753-4887.1990.tb02888.x","article-title":"Malnutrition in patients with AIDS","volume":"48","author":"Hecker","year":"1990","journal-title":"Nutr Rev"},{"key":"10.1054\/clnu.2001.0429_RF3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-1007389","article-title":"Wasting in the acquired immunodeficiency syndrome","volume":"12","author":"Grundfeld","year":"1992","journal-title":"Semin Liver Dis"},{"key":"10.1054\/clnu.2001.0429_RF4","first-page":"1","volume":"41","year":"1992","journal-title":"MMWR"},{"key":"10.1054\/clnu.2001.0429_RF5","doi-asserted-by":"crossref","first-page":"238S","DOI":"10.1093\/jn\/129.1.238S","article-title":"Wasting in HIV infection and AIDS","volume":"129","author":"Macallan","year":"1999","journal-title":"J Nutr"},{"key":"10.1054\/clnu.2001.0429_RF6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00075197-199807000-00011","article-title":"HIV infection and malnutrition","volume":"1","author":"Schwenk","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1054\/clnu.2001.0429_RF7","first-page":"366","article-title":"Weight loss prior to clinical AIDS as a predictor of survival","volume":"10","author":"Palenicek","year":"1995","journal-title":"J AIDS"},{"key":"10.1054\/clnu.2001.0429_RF8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0899-9007(99)00210-5","article-title":"Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients","volume":"15","author":"Melchior","year":"1999","journal-title":"Nutrition"},{"key":"10.1054\/clnu.2001.0429_RF9","first-page":"80","article-title":"Weight loss as a predictor of survival and disease progression in HIV infection: Terry Beirn Community Programs for Clinical Research on AIDS","volume":"18","author":"Wheeler","year":"1998","journal-title":"J AIDS"},{"key":"10.1054\/clnu.2001.0429_RF10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-121-6-199409150-00002","article-title":"Megestrol acetate in patients with AIDS and cachexia","volume":"121","author":"Oster","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1054\/clnu.2001.0429_RF11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.96.4.696","article-title":"Gastrostomy tube supplementation for HIV-infected children","volume":"96","author":"Miller","year":"1995","journal-title":"Pediatrics"},{"key":"10.1054\/clnu.2001.0429_RF12","first-page":"1817","article-title":"Percutaneous endoscopic gastrostomy in AIDS and control patients: risks and outcome","volume":"91","author":"Ockenga","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1054\/clnu.2001.0429_RF13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/aid.1997.13.1047","article-title":"The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with human immunodeficiency virus","volume":"13","author":"Haslett","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1054\/clnu.2001.0429_RF14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002030-199801000-00007","article-title":"A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and \u03a9-3 fatty acids in HIV-infected patients","volume":"12","author":"Pichard","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF15","first-page":"2717","article-title":"Transdermal testosterone administration in women with acquired immunodeficiency wasting: a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9343(99)00193-X","article-title":"The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection","volume":"107","author":"Dobs","year":"1999","journal-title":"Am J Med"},{"key":"10.1054\/clnu.2001.0429_RF17","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199906033402207","article-title":"Treatments for wasting in patients with the acquired immunodeficiency syndrome","volume":"340","author":"Corcoran","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1054\/clnu.2001.0429_RF18","unstructured":"European Centre for the Epidemiological Monitoring of AIDS, HIV\/AIDS Surveillance in Europe, 61, 1999"},{"key":"10.1054\/clnu.2001.0429_RF19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1572-0241.2000.01768.x","article-title":"Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy","volume":"95","author":"Monkemuller","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1054\/clnu.2001.0429_RF20","first-page":"1658","article-title":"Remission of AIDS-associated intestinal microsporidosis with highly active antiretroviral therapy","volume":"11","author":"Goguel","year":"1997","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(97)07529-6","article-title":"Treatment of HIV-1-associated microsporidosis and cryptosporidiosis with combination antiretroviral therapy","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.283.3.381","article-title":"Antiretroviral therapy in adults. Updated Recommendations of the International AIDS Society-USA panel","volume":"283","author":"Carpenter","year":"2000","journal-title":"JAMA"},{"key":"10.1054\/clnu.2001.0429_RF23","first-page":"685","article-title":"Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients","volume":"12","author":"L\u00f3pez-Su\u00e1rez","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF24","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet."},{"key":"10.1054\/clnu.2001.0429_RF26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0889-8553(05)70301-0","article-title":"Malnutrition in HIV infection","volume":"26","author":"Babameto","year":"1997","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1054\/clnu.2001.0429_RF27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0016-5085(96)70039-2","volume":"111","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1054\/clnu.2001.0429_RF28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00002030-199907300-00004","article-title":"Epidemiological and clinical aspects of the metabolic complications of HIV infection. The fat redistribution syndrome","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF29","first-page":"S197","article-title":"HIV-associated lipodystrophy syndrome","volume":"14","author":"Mauss","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF30","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1054\/clnu.2001.0429_RF31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0026-0495(95)90009-8","article-title":"Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss","volume":"44","author":"Selberg","year":"1995","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1079\/PNS19970077","article-title":"Energy metabolism in cancer and human immunodeficiency virus infection","volume":"56","author":"Jebb","year":"1997","journal-title":"Proceedings of the Nutrition Society"},{"key":"10.1054\/clnu.2001.0429_RF33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajcn\/68.3.720","article-title":"Determinants of increased energy expenditure in HIV-infected women","volume":"68","author":"Grinspoon","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0026-0495(90)90092-Q","article-title":"Increased resting energy expenditure in human immunodeficiency virus-infected men","volume":"39","author":"Hommes","year":"1990","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ajcn\/54.2.311","article-title":"Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage","volume":"54","author":"Hommes","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ajcn\/53.2.437","article-title":"Resting energy expenditure is increased in stable, malnourished HIV-infected patients","volume":"53","author":"Melchior","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199404000-00013","article-title":"Diet-induced thermogenesis in HIV infection","volume":"8","author":"Poizot-Martin","year":"1994","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00002030-199610000-00010","article-title":"Energy balance in asymptomatic HIV infection","volume":"10","author":"Sharpstone","year":"1996","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF39","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0026-0495(97)90238-9","article-title":"Total energy expenditure in human immunodeficiency virus-infected men and healthy controls","volume":"46","author":"Heijligenberg","year":"1997","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1749-6632.2000.tb06522.x","article-title":"Positive impact of protease inhibitors on body composition and energy expenditure in HIV-infected and AIDS patients","volume":"904","author":"Schindler","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1054\/clnu.2001.0429_RF41","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/00002030-199815000-00007","article-title":"Effect of malabsorption on nutritional status and resting energy expenditure in HIV-infected patients","volume":"12","author":"Jim\u00e9nez-Exp\u00f3sito","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcn\/51.1.7","article-title":"Preservation of short-term energy balance in clinically stable patients with AIDS","volume":"51","author":"Kotler","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF43","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/00002030-199611000-00011","article-title":"The metabolic response to opportunistic infections in AIDS","volume":"10","author":"Sharpstone","year":"1996","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcn\/55.2.455","article-title":"Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficieny virus infection and the acquired immunodeficiency syndrome","volume":"55","author":"Grunfeld","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF45","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ajcn\/57.5.614","article-title":"Resting energy expenditure in human immunodeficiency virus-infected patients: comparisons between patients with and without secondary infections","volume":"57","author":"Melchior","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0148607100024006317","article-title":"Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections","volume":"24","author":"Garc\u0131\u0301a-Lorda","year":"2000","journal-title":"J Parent Ent Nutr"},{"key":"10.1054\/clnu.2001.0429_RF47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0026-0495(93)90277-U","article-title":"Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients","volume":"42","author":"S\u00fcttmann","year":"1993","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0899-9007(96)00174-8","article-title":"Resting energy expenditure, weight loss and altered body composition in HIV infection","volume":"12","author":"Schwenk","year":"1996","journal-title":"Nutrition"},{"key":"10.1054\/clnu.2001.0429_RF49","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1111\/j.1572-0241.2000.03365.x","article-title":"Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection","volume":"95","author":"Knox","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1054\/clnu.2001.0429_RF50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/thx.51.8.819","article-title":"Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease","volume":"51","author":"Schols","year":"1996","journal-title":"Thorax"},{"key":"10.1054\/clnu.2001.0429_RF51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J Surg"},{"key":"10.1054\/clnu.2001.0429_RF52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ajcn\/61.4.818","article-title":"Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection","volume":"61","author":"Macallan","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF53","first-page":"404","article-title":"Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome","volume":"78","author":"Lieberman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF54","first-page":"E577","article-title":"Increased plasma Gln and Leu Ra and inappropiately low muscle protein synthesis rate in AIDS wasting","volume":"275","author":"Yarasheski","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1054\/clnu.2001.0429_RF55","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0026-0495(90)90136-Z","article-title":"Protein and energy substrate metabolism in AIDS patients","volume":"39","author":"Stein","year":"1990","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF56","first-page":"209A","article-title":"Protein turnover and resting metabolic rate (RMR) are normal in asymptomatic HIV-infected men","volume":"43","author":"Salbe","year":"1995","journal-title":"Clin Res"},{"key":"10.1054\/clnu.2001.0429_RF57","first-page":"559","article-title":"Increased de novo hepatic lipogenesis in human immunodeficiency virus-infected humans","volume":"76","author":"Hellerstein","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ajcn\/68.1.154","article-title":"De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting","volume":"68","author":"Hoh","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0899-9007(98)00108-7","article-title":"Role of cytokines in AIDS wasting","volume":"14","author":"Chang","year":"1998","journal-title":"Nutrition"},{"key":"10.1054\/clnu.2001.0429_RF60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/ajcn\/58.5.715a","article-title":"Tumor necrosis factor and resting energy expenditure during the acquired immunodeficiency syndrome","volume":"58","author":"Salehian","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF61","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/0026-0495(95)90076-4","article-title":"Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection","volume":"44","author":"Godfried","year":"1995","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199701023360115","article-title":"Energy expenditure in human immunodeficiency virus infection","volume":"336","author":"Mulligan","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1054\/clnu.2001.0429_RF63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ajcn.70.2.299","article-title":"Hypermetabolism and progression of HIV infection","volume":"70","author":"Garc\u0131\u0301a Luna","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/clnu.2001.0429_RF64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/362355a0","article-title":"HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease","volume":"362","author":"Pantaleo","year":"1993","journal-title":"Nature"},{"key":"10.1054\/clnu.2001.0429_RF65","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00002030-199907300-00012","article-title":"Elevated resting energy expenditure among seropositive persons receiving highly active antiretroviral therapy","volume":"13","author":"Shevitz","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF66","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1097\/00002030-199912030-00010","article-title":"Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients","volume":"13","author":"Pernerstorfer-Schoen","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF67","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1054\/clnu.2001.0429_RF68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199507133330202","article-title":"Energy expenditure and wasting in human immunodeficiency virus infection","volume":"333","author":"Macallan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1054\/clnu.2001.0429_RF69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/cs0910241","article-title":"Total energy expenditure and physical activity measured with the bicarbonate-urea method in patients with human immunodeficiency virus infection","volume":"91","author":"Paton","year":"1996","journal-title":"Clin Sci"},{"key":"10.1054\/clnu.2001.0429_RF70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1054\/clnu.2001.0429_RF71","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF72","first-page":"329","article-title":"Metabolic disturbances and wasting in the acquired immunodeficiency syndrome","volume":"273","author":"Grunfeld","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1054\/clnu.2001.0429_RF73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/jn\/122.suppl_3.749","article-title":"The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertrigliceridemia and wasting of AIDS","volume":"122","author":"Grunfeld","year":"1992","journal-title":"J Nutr"},{"key":"10.1054\/clnu.2001.0429_RF74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(91)90536-7","article-title":"Circulating interferon- \u03b1 levels and hypertrigliceridemia in the acquired immunodeficiency syndrome","volume":"90","author":"Grunfeld","year":"1991","journal-title":"Am J Med"},{"key":"10.1054\/clnu.2001.0429_RF75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0140-6736(92)91058-G","article-title":"Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex","volume":"339","author":"Mildvan","year":"1992","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF76","first-page":"1149","article-title":"Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation","volume":"7","author":"Zangerle","year":"1994","journal-title":"J Acq Immun Def Synd"},{"key":"10.1054\/clnu.2001.0429_RF77","first-page":"1423","article-title":"The hypertriglyceridemia of AIDS is associated with an increased prevalence of LDL subclass pattern B","volume":"76","author":"Feingold","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acq Immun Def Synd Hum Retrovirol"},{"key":"10.1054\/clnu.2001.0429_RF79","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance due to HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF80","first-page":"107","article-title":"Changes in body habits and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)","volume":"21","author":"Dong","year":"1999","journal-title":"J Acq Immun Def Synd Hum Retrovirol"},{"key":"10.1054\/clnu.2001.0429_RF81","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF82","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF83","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitors","volume":"351","author":"Henry","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF84","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00126334-200003010-00009","article-title":"Serum triglycerides, HIV infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998","volume":"23","author":"Thiebaut","year":"2000","journal-title":"J Acq Immun Def Synd"},{"key":"10.1054\/clnu.2001.0429_RF86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/cs0840209","article-title":"Non-insulin-mediated glucose uptake in human immunodeficiency virus-infected men","volume":"84","author":"Heijligenberg","year":"1993","journal-title":"Clin Sci"},{"key":"10.1054\/clnu.2001.0429_RF87","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0026-0495(91)90059-6","article-title":"Insulin sensitivity and insulin clearance in human immunodeficiency virus infected men","volume":"40","author":"Hommes","year":"1991","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF88","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF89","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(05)60719-2","article-title":"Metabolics abnormalities and use of HIV-1 protease inhibitors","volume":"352","author":"Mart\u0131\u0301nez","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF90","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","article-title":"Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy","volume":"84","author":"Yanovski","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF91","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"352","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF92","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/317491","article-title":"Disorders of glucose metabolism in patients infected with human immunodeficiency virus","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1054\/clnu.2001.0429_RF93","first-page":"127","article-title":"New-onset diabetes mellitus associated with the use of protease inhibitors","volume":"948","author":"Eastone","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1054\/clnu.2001.0429_RF94","first-page":"41","article-title":"Metabolic complications of antiretroviral therapies","volume":"10","author":"Dube","year":"1998","journal-title":"AIDS Clin Care"},{"key":"10.1054\/clnu.2001.0429_RF95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00126334-199907010-00005","article-title":"Insulin resistance in HIV protease inhibitor-associated diabetes","volume":"21","author":"Yarasheski","year":"1999","journal-title":"J Acq Immun Def Synd"},{"key":"10.1054\/clnu.2001.0429_RF96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1054\/clnu.2001.0429_RF97","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00002030-199907300-00013","article-title":"Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS","volume":"13","author":"Shikuma","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF98","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(98)26026-0","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Behrens","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF99","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00002030-199815000-00024","article-title":"Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?","volume":"12","author":"Ericksson","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF100","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: The Frankfurt HIV-cohort study","volume":"5","author":"Rickerts","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1054\/clnu.2001.0429_RF101","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1097\/00002030-200011100-00001","article-title":"Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors","volume":"14","author":"Maggi","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF102","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/00002030-199909100-00034","article-title":"Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?","volume":"13","author":"Jutte","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF103","first-page":"185","article-title":"Bone remodelling in human immunodeficiency virus-1-infected patients","volume":"16","author":"Serrano","year":"1995","journal-title":"A histomorphometric study. Bone"},{"key":"10.1054\/clnu.2001.0429_RF104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s002239900288","article-title":"Bone mineral density in patients with human immunodeficiency virus infection","volume":"61","author":"Paton","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1054\/clnu.2001.0429_RF105","first-page":"145","article-title":"Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy","volume":"84","author":"Aukrust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF106","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/meta.2000.8609","article-title":"Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection","volume":"49","author":"Teichmann","year":"2000","journal-title":"Metabolism"},{"key":"10.1054\/clnu.2001.0429_RF107","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF108","first-page":"18","article-title":"Serum and urine markers of bone mineral metabolism in HIV infected patients taking protease inhibitor containing potent antiretroviral therapy","volume":"5","author":"Tebas","year":"2000","journal-title":"Antiviral Ther"},{"key":"10.1054\/clnu.2001.0429_RF109","first-page":"20","article-title":"Osteopenia in HIV-infected men: association with lactic acidemia and lower weight pre-antiretroviral therapy","volume":"5","author":"Carr","year":"2000","journal-title":"Antiviral Ther"},{"key":"10.1054\/clnu.2001.0429_RF110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00126334-200009010-00003","article-title":"Osteonecrosis in HIV: A case-control study","volume":"25","author":"Scribner","year":"2000","journal-title":"J Acq Immun Def Synd Hum Retrovirol"},{"key":"10.1054\/clnu.2001.0429_RF111","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF112","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF113","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00002030-199811000-00024","article-title":"Marked hypertriglyceridemia on ritonavir","volume":"12","author":"Sullivan","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF114","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0006-2952(00)00246-X","article-title":"Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir","volume":"59","author":"Lenhard","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1054\/clnu.2001.0429_RF115","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF116","unstructured":"Stevens, G, J, Chen, M, Grecko, R, Investigations into the proposed mechanisms of HIV-associated peripheral lipodistrophy, hyperlipidaemia and insulin resistance, 1999"},{"key":"10.1054\/clnu.2001.0429_RF117","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(05)60074-8","article-title":"Protease inhibitors and adipocyte differentiation in cell culture","volume":"352","author":"Gagnon","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF118","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/00002030-200011100-00007","article-title":"Ritonavir increases the level of active ADD-1\/SREBP-1 protein during adipogenesis","volume":"14","author":"Nguyen","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF119","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-5793(99)00540-2","article-title":"Tumour necrosis factor, a key role in obesity?","volume":"451","author":"Bull\u00f3-Bonet","year":"1999","journal-title":"FEBS Letters"},{"key":"10.1054\/clnu.2001.0429_RF120","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1054\/clnu.2001.0429_RF121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/377151a0","article-title":"Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4","volume":"377","author":"Katz","year":"1995","journal-title":"Nature"},{"key":"10.1054\/clnu.2001.0429_RF122","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1345\/aph.19231","article-title":"Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population","volume":"34","author":"Dever","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1054\/clnu.2001.0429_RF123","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF124","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine","volume":"13","author":"Mart\u0131\u0301nez","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF126","first-page":"8","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative subjects","volume":"5","author":"Noor","year":"2000","journal-title":"Antiviral Ther"},{"key":"10.1054\/clnu.2001.0429_RF127","first-page":"1932","article-title":"Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women","volume":"84","author":"Hadigan","year":"1999","journal-title":"J Clin Endocrin Metab"},{"key":"10.1054\/clnu.2001.0429_RF128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199904160-00020","article-title":"Lipodystrophy in patients naive to HIV protease inhibitors","volume":"13","author":"Madge","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00002030-199905070-00021","article-title":"Lipodystrophy associated with nevirapine-containing antiretroviral therapies","volume":"13","author":"Aldeen","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF130","first-page":"35","article-title":"Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use","volume":"85","author":"Hadigan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF132","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF133","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.44.5.862","article-title":"Multiple symmetric lipomatosis: abnormalities in complex IV and multiple deletions in mitochondrial DNA","volume":"44","author":"Klopstock","year":"1994","journal-title":"Neurology"},{"key":"10.1054\/clnu.2001.0429_RF134","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of mitochondrial DNA in AIDS patients with zidovudine induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"10.1054\/clnu.2001.0429_RF136","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/169.2.420","article-title":"Serum levels of tumor necrosis factor- \u03b1 (TNF- \u03b1) and soluble receptors in human immunodeficiency virus type 1 infection: correlations to clinical, immunologic, and virologic parameters","volume":"169","author":"Aukrust","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1054\/clnu.2001.0429_RF137","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199611000-00001","article-title":"Plasma levels of soluble CD30, tumor necrosis factor (TNF)- \u03b1 and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome","volume":"10","author":"Rizzardi","year":"1996","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF138","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.1997.d01-2031.x","article-title":"Inadequate erythropoietin response to anaemia in HIV patients: relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors","volume":"96","author":"Kreuzer","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/clnu.2001.0429_RF139","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/clin.1997.4364","article-title":"Relationship of plasma HIV-RNA levels and levels of TNF- \u03b1 and immune activation products in HIV infection","volume":"84","author":"Salazar-Gonzalez","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1054\/clnu.2001.0429_RF140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jlb.62.1.60","article-title":"Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients","volume":"62","author":"Cassone","year":"1997","journal-title":"J Leukocyte Biol"},{"key":"10.1054\/clnu.2001.0429_RF141","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-124-8-199604150-00009","article-title":"Plasma cytokine antagonists, and disease progression in African women infected with HIV-1","volume":"124","author":"Thea","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1054\/clnu.2001.0429_RF142","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0022-2275(20)38211-0","article-title":"Cachectin\/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity","volume":"30","author":"Fried","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1054\/clnu.2001.0429_RF143","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1016\/S0021-9258(18)54714-1","article-title":"Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha","volume":"266","author":"Stephens","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1054\/clnu.2001.0429_RF144","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/endo.134.6.8194485","article-title":"Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase","volume":"134","author":"Green","year":"1994","journal-title":"Endocrinology"},{"key":"10.1054\/clnu.2001.0429_RF145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800826","article-title":"Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects","volume":"23","author":"Corica","year":"1999","journal-title":"Int J Obes Related Metab Disord"},{"key":"10.1054\/clnu.2001.0429_RF146","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1083\/jcb.108.3.1105","article-title":"Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta","volume":"108","author":"Torti","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1054\/clnu.2001.0429_RF147","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diab.46.12.1939","article-title":"Tumor necrosis factor-alpha induces apoptosis of human adipose cells","volume":"46","author":"Prins","year":"1997","journal-title":"Diabetes"},{"key":"10.1054\/clnu.2001.0429_RF148","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifi","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1054\/clnu.2001.0429_RF149","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of tumor necrosis factor- \u03b1 T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"10.1054\/clnu.2001.0429_RF150","first-page":"716","article-title":"Evolution of tumor necrosis factor- \u03b1 serum concentrations in HIV infected individuals treated with zidovudine","volume":"44","author":"Morlat","year":"1996","journal-title":"Pathol Biol"},{"key":"10.1054\/clnu.2001.0429_RF151","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acq Immun Def Synd"},{"key":"10.1054\/clnu.2001.0429_RF152","unstructured":"Maher, B, Alfirevic, A, Vilar, J, Wilkins, E, Park, B, K, Pirmohamed, M, Tumour necrosis factor-alpha (TNF- \u03b1) promoter region gene polymorphisms in patients with HIV-1 associated lipodystrophy, 2000"},{"key":"10.1054\/clnu.2001.0429_RF153","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/jcem.83.5.4951","article-title":"Obesity and gender influence cortisol secretion and metabolism in man","volume":"83","author":"Andrew","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/clnu.2001.0429_RF154","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0306-4530(97)00015-2","article-title":"Serum cortisol and DHEA concentrations during HIV infection","volume":"22","author":"Christeff","year":"1997","journal-title":"Psychoneuroendocrino"},{"key":"10.1054\/clnu.2001.0429_RF155","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations","volume":"13","author":"Christeff","year":"1999","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF156","first-page":"1025","article-title":"The influence of the human immunodeficiency virus on resting energy expenditure","volume":"7","author":"Slusarczyk","year":"1994","journal-title":"J Acq Immun Def Synd"},{"key":"10.1054\/clnu.2001.0429_RF157","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00002030-200004140-00007","article-title":"Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus","volume":"14","author":"Johann-Liang","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF158","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-200007070-00027","article-title":"Beta3-adrenergic receptor polymorphism and the antiretroviral therapy-related lipodystrophy syndrome","volume":"14","author":"Vonkeman","year":"2000","journal-title":"AIDS"},{"key":"10.1054\/clnu.2001.0429_RF159","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(05)75347-2","article-title":"ApoE genotype and protease-inhibitor-associated hyperlipidaemia","volume":"354","author":"Behrens","year":"1999","journal-title":"Lancet"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561401904297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561401904297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:18:22Z","timestamp":1682140702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561401904297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":159,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0261561401904297"],"URL":"https:\/\/doi.org\/10.1054\/clnu.2001.0429","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}